RYTM Smart Money
Rhythm Pharmaceuticals, Inc.
1W: +2.2%
1M: -6.5%
3M: -13.5%
YTD: -12.2%
1Y: -16.6%
3Y: +319.0%
5Y: +738.8%
$92.18
+2.71 (+3.03%)
Weekly Expected Move ±4.1%
$82
$86
$89
$93
$97
Credit Risk of going bust: lower than 94% of companies Debt: 0.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down more than 99.9%), Rhythm Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $3.7M against a stock market value of $6.35B.
Distance to default 17.55 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.8M (short-term plus half of long-term), stock volatility 46.1%; Altman Z'' -8.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down more than 99.9%), Rhythm Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $3.7M against a stock market value of $6.35B.
Distance to default 17.55 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.8M (short-term plus half of long-term), stock volatility 46.1%; Altman Z'' -8.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026347
Institutions Holding
+11 vs prior
131.1%
Ownership
+32.20%
65
New
106
Increased
142
Reduced
41
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-14 | Meeker David P | officer: president and ceo | S-Sale | 30,746 | $102.35 | $3.1M | Filing |
| 2026-09-14 | Meeker David P | officer: president and ceo | S-Sale | 2,300 | $105.19 | $242K | Filing |
| 2026-09-14 | Meeker David P | officer: president and ceo | S-Sale | 1,817 | $104.55 | $190K | Filing |
| 2026-09-14 | Meeker David P | officer: president and ceo | S-Sale | 8,698 | $103.43 | $900K | Filing |
| 2026-09-14 | Meeker David P | officer: president and ceo | S-Sale | 6,439 | $101.75 | $655K | Filing |
| 2026-08-31 | Smith Hunter C | officer: chief financial officer | S-Sale | 23,072 | $104.59 | $2.4M | Filing |
| 2026-08-31 | Smith Hunter C | officer: chief financial officer | S-Sale | 11,514 | $105.37 | $1.2M | Filing |
| 2026-08-31 | Smith Hunter C | officer: chief financial officer | S-Sale | 28,188 | $106.20 | $3.0M | Filing |
| 2026-08-13 | Lee Jennifer Kayden | officer: evp, head of north america | S-Sale | 75,834 | $117.38 | $8.9M | Filing |
| 2026-08-13 | Shulman Joseph | officer: chief technical officer | S-Sale | 5,079 | $119.75 | $608K | Filing |
| 2026-08-13 | Garfield Alastair | officer: chief scientific officer | S-Sale | 2,007 | $116.11 | $233K | Filing |
| 2026-08-13 | Garfield Alastair | officer: chief scientific officer | S-Sale | 1,556 | $117.08 | $182K | Filing |
| 2026-08-13 | Garfield Alastair | officer: chief scientific officer | S-Sale | 3,400 | $118.28 | $402K | Filing |
| 2026-08-13 | Garfield Alastair | officer: chief scientific officer | S-Sale | 800 | $119.17 | $95K | Filing |
| 2026-08-12 | Mazabraud Yann | officer: evp, head of international | S-Sale | 2,300 | $111.80 | $257K | Filing |
| 2026-08-12 | Mazabraud Yann | officer: evp, head of international | S-Sale | 1,000 | $112.86 | $113K | Filing |
| 2026-08-12 | Mazabraud Yann | officer: evp, head of international | S-Sale | 3,605 | $114.70 | $413K | Filing |
| 2026-08-12 | Mazabraud Yann | officer: evp, head of international | S-Sale | 14,568 | $115.43 | $1.7M | Filing |
| 2026-08-12 | Mazabraud Yann | officer: evp, head of international | S-Sale | 18,208 | $116.49 | $2.1M | Filing |
| 2026-08-12 | Mazabraud Yann | officer: evp, head of international | S-Sale | 17,319 | $117.47 | $2.0M | Filing |
| 2026-07-01 | Garfield Alastair | officer: chief scientific officer | F-Tax Withholding | 2,150 | $110.41 | $237K | Filing |
| 2026-06-22 | TETRAULT LYNN A. | director | S-Sale | 37,000 | $100.32 | $3.7M | Filing |
| 2026-05-15 | German Christopher Paul | officer: corporate controller & cao | S-Sale | 4,643 | $92.21 | $428K | Filing |
| 2026-04-01 | Mazabraud Yann | officer: evp, head of international | M-Option Exercise | 12,875 | $— | $0 | Filing |
| 2026-03-12 | Mathers Edward T | director | J-J | 4,199 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 6,666,837 | $740M | — | 2026-06-30 | Filing |
| BlackRock, Inc. | 6,156,902 | $684M | -80,249 | 2026-06-30 | Filing |
| BAKER BROS. ADVISORS LP | 5,604,483 | $622M | — | 2026-06-30 | Filing |
| PRIMECAP MANAGEMENT CO/CA | 3,168,853 | $352M | -248,656 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3,136,895 | $348M | +96,177 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,005,977 | $334M | +38,152 | 2026-06-30 | Filing |
| JPMORGAN CHASE & CO | 2,652,746 | $292M | +1,099,102 | 2026-06-30 | Filing |
| PERCEPTIVE ADVISORS LLC | 2,586,295 | $287M | +212,500 | 2026-06-30 | Filing |
| STATE STREET CORP | 2,573,529 | $286M | +301,678 | 2026-06-30 | Filing |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,208,595 | $245M | +279,472 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 2,126,502 | $236M | +161,070 | 2026-06-30 | Filing |
| FEDERATED HERMES, INC. | 1,785,716 | $198M | +499,413 | 2026-06-30 | Filing |
| Polar Capital Holdings Plc | 1,663,632 | $185M | +48,046 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,533,698 | $170M | +117,429 | 2026-06-30 | Filing |
| Capital Research Global Investors | 1,532,303 | $170M | +416,843 | 2026-06-30 | Filing |
| CITADEL ADVISORS LLC | 1,263,652 | $140M | -154,967 | 2026-06-30 | Filing |
| Checkpoint Capital L.P. | 1,186,000 | $132M | -41,200 | 2026-06-30 | Filing |
| Siren, L.L.C. | 1,136,275 | $126M | +410,764 | 2026-06-30 | Filing |
| MORGAN STANLEY | 1,112,240 | $123M | +408,262 | 2026-06-30 | Filing |
| FMR LLC | 1,025,840 | $114M | -663,831 | 2026-06-30 | Filing |